New drug cuts seizures by up to 91% in children with rare epilepsy

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91% while also improving quality of life for many patients. The therapy works by boosting the function of a key gene involved in nerve cell signaling. Encouraging results have led researchers to launch a larger Phase 3 trial.

Health Mar 5, 2026 0 10 Add to Reading List

New drug cuts seizures by up to 91% in children with rare epilepsy

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

It’s an amazing story, composed out of imagination and rich with lessons. You’ll learn how to be morally upright, avoid immoral things, and understand how words can make or destroy peace and harmony.

Click the image to get your copy!

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

Click the image to get your copy!

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

Click the image to get your copy!

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91% while also improving quality of life for many patients. The therapy works by boosting the function of a key gene involved in nerve cell signaling. Encouraging results have led researchers to launch a larger Phase 3 trial.

Read Original